Phathom Pharmaceuticals Inc (PHAT)
9.34
-0.11
(-1.16%)
USD |
NASDAQ |
Nov 22, 16:00
9.32
-0.02
(-0.21%)
After-Hours: 20:00
Phathom Pharmaceuticals Total Liabilities (Quarterly): 574.16M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 574.16M |
| June 30, 2024 | 553.20M |
| March 31, 2024 | 505.00M |
| December 31, 2023 | 486.60M |
| September 30, 2023 | 254.76M |
| June 30, 2023 | 247.44M |
| March 31, 2023 | 234.20M |
| December 31, 2022 | 239.62M |
| September 30, 2022 | 228.35M |
| June 30, 2022 | 220.50M |
| March 31, 2022 | 111.01M |
| December 31, 2021 | 117.28M |
| Date | Value |
|---|---|
| September 30, 2021 | 124.90M |
| June 30, 2021 | 82.45M |
| March 31, 2021 | 82.02M |
| December 31, 2020 | 100.84M |
| September 30, 2020 | 74.50M |
| June 30, 2020 | 64.00M |
| March 31, 2020 | 55.22M |
| December 31, 2019 | 29.22M |
| September 30, 2019 | 232.17M |
| June 30, 2019 | 169.26M |
| December 31, 2018 | 2.188M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
29.22M
Minimum
Dec 2019
574.16M
Maximum
Sep 2024
219.26M
Average
172.70M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
| Oragenics Inc | 2.126M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 387.04M |
| Shareholders Equity (Quarterly) | -187.11M |
| Debt to Equity Ratio | -0.9392 |
| Current Ratio | 5.726 |
| Net Debt Paydown Yield | -0.44% |